Prostate cancer often presents no signs or symptoms. Therefore, skilled urologists on staff at the Beaumont Cancer Institute bring their experience and knowledge to bear in diagnosing and treating prostate cancer. They can determine if an enlarged prostate is benign or associated with cancer. Confidently, they are backed by the laboratories at Beaumont that perform 11 million tests a year.
For patients with prostate cancer, Beaumont continues to be one of the most progressive institutions, employing all of the latest innovative technologies and treatment techniques to find the personal treatment plan with the best chance of success.
In 2015, nearly 700 patients were diagnosed with prostate cancer at Beaumont's cancer center in Michigan. Our high quality of care is reflected in survival rates that exceed the national average, which is 94.3 percent for all prostate cancer stages at five years after the diagnosis of prostate cancer.